July 2017
Table of Contents

Funding Opportunities

Prevention Programs - Competitive Continuation/Expansion - Evidence-Based Cancer Prevention Services 



Expanding Genome Integrity Assays to Population Studies (U01)



View a full list of current funding opportunities. 

Highlighted positions related to cancer for which VCU is currently hiring. View the full list.


Associate Director, Basic Research (F51620)


Program Co-Leader, Cancer Molecular Genetics (F36090)

Shared Resource Spotlight
JEOL JEM-1400 Plus TEM

The VCU Microscopy Facility, housed within the Department of Anatomy and Neurobiology in Sanger Hall, has recently completed the installation of a new transmission electron microscope (TEM). The JEOL JEM-1400 Plus TEM replaces the JEM-1230 that has been available in the core for 13 years. The new high-resolution 120kV TEM can image specimens from 200x to about 1,200,000x, with a maximum resolution of 3.4 A. The microscope includes the Gatan's OneView 

16-Megapixel CMOS camera, giving ultra-high-definition resolution and real-time drift correction to images.


For more information, contact Judy Williamson at 

828-0949 or judy.williamson@vcuhealth.org or visit the Massey website

Leaders' Update Update 
A message from Director Gordon Ginder

Dear colleagues,

I am pleased to announce that 
we recently received the official award notice from the National Cancer Institute for our Cancer Center Support Grant, which provides Massey with  $11 million in funding through 
2022 and effectively renews 
our designation as an NCI 
Cancer Center.

This message continues with more about the renewal of Massey's NCI designation.

Research HighlightsHighlights
Study uncovers potential 'silver bullet' for preventing and treating colon cancer

Cancer Molecular Genetics member and Developmental Therapeutics co-leader
In preclinical experiments, Massey researchers led by Steven Grossman uncovered a new way in which colon cancer develops as well as a potential "silver bullet" for preventing and treating it. They targeted the gene CtBP with a drug known as HIPP and were able to reduce the development of  pre-cancerous polyps by half and return a normal lifespan to mice born with a predisposition to intestinal polyps.


Center News Center1
Massey re-designated by the National Cancer Institute for the 42nd year

Massey renewed its National Cancer Institute designation for the 42nd year. The renewal extends to 2022 and includes a Cancer Center Support Grant of $11 million to support research, clinical trials, education and training. Massey had significant progress to report over the 
5-year review period, including the recruitment of 36 new faculty, as well as increased cancer research funding, 
high-impact scientific publications and the translation of new scientific findings into clinical trials.

Member Showcase MemberShowcase

Gil studies the relationship of cholesterol to colon cancer growth

 Cancer Cell Signaling member
Gregorio Gil joined Massey as a member of the Cancer Cell Signaling research program in 2017. His studies primarily focus on the functions of cholesterol in the development of colon cancer in order to identify targets for novel therapies to treat or prevent the disease. Gil is a professor in the Department of Biochemistry and Molecular Biology at the VCU School of Medicine.

Researcher Recognition Recognition
Corey awarded $250,000 from Alex's Lemonade Stand Foundation

Cancer Molecular Genetics member
Seth Corey received a $250,000 Innovation Award from Alex's Lemonade Stand Foundation to determine which children with an inherited bone marrow failure syndrome would benefit most from stem cell transplantation at an early stage using precision medicine and computer models. The 
two-year funding will be used to create software based on mouse models that can identify those risk factors and inform the use of personalized therapies for the prevention or treatment of myeloid malignancies in children.

For a full listing of events, 

mediaMassey in the Media

NewsTop Cancer News

Centers for Disease Control and Prevention
A report indicated that cancer death rates are higher in rural areas than in urban areas. The report was covered by CBS News, Reuters and The Washington Post.

U.S. Food and Drug Administration
An FDA panel recommended approval of the first gene therapy for treatment in blood cancers. The recommendation was reported by  CNNThe New York Times and  The Washington Post.
Share with us your research, awards and accomplishments!
Submit your news to Blake Belden at beldenba@vcu.edu or (804) 628-4578.
  Connect with us!
Join Massey's online communities.
Like us on Facebook
Follow us on Twitter
View our videos on YouTube